Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Skin”

16,330 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 16,330 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 24
Early research (Phase 1)Study completedNCT00085488
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center
Not applicableStudy completedNCT04190342
What this trial is testing

Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients

Who this might be right for
Breast Neoplasm FemaleSymptom ClusterTai ji
Charles Darwin University 72
Testing effectiveness (Phase 2)Study completedNCT00820170
What this trial is testing

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 55
Not applicableStudy completedNCT00773669
What this trial is testing

Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Who this might be right for
Breast Cancer
Summa Health System 24
Not applicableUnknownNCT05394194
What this trial is testing

Dosimetric Comparison of Three Radiation Techniques for Hypofractionated Whole Breast Radiotherapy in Early Breast Cancer

Who this might be right for
Breast Cancer
Sohag University 30
Testing effectiveness (Phase 2)Ended earlyNCT04375527
What this trial is testing

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more
Jonsson Comprehensive Cancer Center 3
Not applicableEnded earlyNCT01806961
What this trial is testing

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Who this might be right for
Actinic Keratosis
Spirig Pharma Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01725386
What this trial is testing

An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 274
Early research (Phase 1)Study completedNCT02914470
What this trial is testing

Carboplatin-cyclophosphamide Combined With Atezolizumab

Who this might be right for
Breast CancerCervix CancerOvarian Cancer+1 more
The Netherlands Cancer Institute 12
Large-scale testing (Phase 3)Looking for participantsNCT07207070
What this trial is testing

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd. 312
Very early researchWithdrawnNCT00606970
What this trial is testing

Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy

Who this might be right for
Cancer
New Hope Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658183
What this trial is testing

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Shanghai Best-Link Bioscience, LLC 120
Not applicableActive Not RecruitingNCT07092254
What this trial is testing

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Daiichi Sankyo 760
Not applicableStudy completedNCT04551105
What this trial is testing

Evaluation of TaiHao Breast Ultrasound Diagnosis Software

Who this might be right for
Breast CancerBreast Diseases
TaiHao Medical Inc. 16
Not applicableStudy completedNCT00314405
What this trial is testing

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

Who this might be right for
Infiltrative Breast Cancer
University Hospital, Strasbourg, France 100
Not applicableStudy completedNCT01873794
What this trial is testing

Treating Cancer-Related Fatigue Through Systematic Light Exposure

Who this might be right for
Hematopoietic Stem Cell TransplantationBreast CancerFatigue+4 more
Icahn School of Medicine at Mount Sinai 54
Large-scale testing (Phase 3)Ended earlyNCT00130494
What this trial is testing

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 97
Next Page